Shenzhen Zhongge Biotechnology patents AMP-activated protein kinase α1β1γ1 activators
Nephrology Shenzhen Zhongge Biotechnology Co. Ltd. has synthesized AMP-activated protein kinase α1β1γ1 activators reported to be useful for the treatment of acute kidney injury, alopecia, chronic kidney disease, diabetes type 2, diabetic nephropathy, …